GC
SAVAW

Guggenheim Capital’s Cassava Sciences, Inc. Warrant SAVAW Stock Holding History

Guggenheim Capital’s Portfolio SAVAW Stock Details SAVAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,900
Closed – – 1973
2024
Q1 		$0 Buy
+17,900
New +$107K ﹤0.01% 1956

Other funds holding SAVAW

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Guggenheim Capital's SAVAW Position: Q2 2024 in Review

Guggenheim Capital sold out of Cassava Sciences, Inc. Warrant (SAVAW) in Q2 2024, closing a stake of 17,900 shares.

Guggenheim Capital first reported a position in SAVAW in Q1 2024 and held it in 1 quarter. The position peaked at $0 in Q1 2024. 3 funds tracked by Wall St. Rank hold SAVAW as of Q2 2024.

  • Guggenheim Capital reported no remaining Cassava Sciences, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
  • Guggenheim Capital sold 17,900 Cassava Sciences, Inc. Warrant shares in Q2 2024.
  • Guggenheim Capital first reported a position in Cassava Sciences, Inc. Warrant in Q1 2024 and held it in 1 quarter.
  • Guggenheim Capital's Cassava Sciences, Inc. Warrant position peaked at $0 in Q1 2024.
  • 3 funds tracked by Wall St. Rank held Cassava Sciences, Inc. Warrant as of Q2 2024.

Based on Guggenheim Capital's 13F filing for Q2 2024, filed 14 Aug 2024.